Clinical Trial Update: Effects of Modulators of Gluconeogenesis, Glycogenolysis and Glucokinase Activity [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update reviewing modulators of gluconeogenesis, glycogenolysis and glucokinase activity in people with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Type 2 Diabetes | Phase 3 | Status: ACTIVE_NOT_RECRUITING